Gefitinib may have chemopreventive benefits in pancreatic cancer
Monday, November 8, 2010 - 14:00
in Health & Medicine
Gefitinib may be a promising chemoprevention agent for pancreatic cancer, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.